UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
176 civic groups furious over government-doctors deal
Labor and civic groups intensely criticized the government for agreeing wit...
by Kim Eun-young
|
2020-09-04 18:14
라인
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
Amgen Korea has received an expanded indication for Blincyto, a treatment f...
by Lee Han-soo
|
2020-09-04 18:04
라인
UBcare wins patent for tech to monitor suspected infectious diseases
UBcare, a company specializing in digital healthcare solutions, said Friday...
by Shim Hyun-tai
|
2020-09-04 18:04
라인
SCM Lifescience punished for delaying adverse reaction report
The Ministry of Food and Drug Safety said it imposed an administrative warn...
by Kim Chan-hyuk
|
2020-09-04 14:54
라인
Doctors to end strike as government puts healthcare policy on hold
The medical community agreed to end the ongoing strike, as the government a...
by Kwak Sung-sun
|
2020-09-04 14:53
라인
Despite slowing down virus cases, tight restrictions continue in Seoul
Korea reported new Covid-19 cases of below 200 for two consecutive days on ...
by Lee Han-soo
|
2020-09-04 14:16
라인
Iraq approves Hutox as 1st BTX product
Huons said that Iraqi health authorities have approved Hutox, its botulinum...
by Lee Han-soo
|
2020-09-04 14:16
라인
Pharmaceuticals, CROs have hard time doing clinical trials amid prolonged pandemic
Amid the protracted Covid-19 pandemic, pharmaceutical and contract research...
by Lee Han-soo
|
2020-09-03 19:24
라인
8 in 10 clinical professors willing to act collectively
About 80 percent of medical school professors across the nation said they w...
by Song Soo-youn
|
2020-09-03 16:29
라인
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
Novavax unveiled the successful results of the phase-1 clinical trial on a ...
by Kim Yun-mi
|
2020-09-03 14:50
라인
‘Cyramza helped improve gastric cancer treatment in Korea’
Lilly’s Cyramza (ingredient: ramucirumab), an inhibitor of vascular endothe...
by Kim Yun-mi
|
2020-09-03 14:49
라인
Chong Kun Dang to conduct P2 trials of Covid-19 therapy in Russia
Chong Kun Dang's anticoagulant and acute pancreatitis treatment Nafabel...
by Shim Hyun-tai
|
2020-09-03 12:36
라인
Daewoong to expand indication of Nabota in US
Daewoong Pharmaceutical said it would enter the treatment market for botuli...
by Lee Han-soo
|
2020-09-03 12:13
라인
New virus cases fall below 200 but critical patients surge
Korea's new Covid-19 cases fell to the lowest level in more than two we...
by Lee Han-soo
|
2020-09-03 11:27
라인
Recovered Covid-19 patients suffer from aftereffects – for long
Many Covid-19 patients have been completely cured by enduring physical and ...
by Shim Hyun-tai
|
2020-09-02 20:12
라인
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
The European Society of Cardiology recently announced the 2020 ESC guidelin...
by Kim Yun-mi
|
2020-09-02 16:33
라인
Nation struggles to secure beds, workforce for severe Covid-19 patients
The Ministry of Health and Welfare is securing more sickbeds and training m...
by Shim Hyun-tai
|
2020-09-02 16:15
라인
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
Researchers at Seoul National University Bundang Hospital (SNUBH) have deve...
by Lee Han-soo
|
2020-09-02 15:20
라인
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
JW Pharmaceutical said Tuesday that its rheumatoid arthritis drug, Actemra ...
by Shim Hyun-tai
|
2020-09-02 14:08
라인
[Column] Correct diagnosis leads to proper treatment
The clash between the government and the medical community over the issue o...
by Shin Eui-cheol
|
2020-09-02 13:10
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top